Dr. Elizabeth Kim Asfaw, MD

Dr. Asfaw practices at Peter Morton UCLA Medical Building in Los Angeles, California.

Dr. Asfaw's NPI, 1699206250, was assigned on March 24, 2017. Dr. Asfaw graduated from David Geffen School of Medicine at UCLA in 2017. Dr. Asfaw holds California license A159728.

Dr. Asfaw's primary practice is Peter Morton UCLA Medical Building, at 200 Medical Plz, Los Angeles, CA 90024 in Los Angeles County. The practice phone is (310) 794-9206.

Dr. Asfaw's primary practice is Peter Morton UCLA Medical Building in Los Angeles, California. Dr. Asfaw is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is UCLA Medical Group. Dmand AI also links Dr. Asfaw to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Asfaw practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Asfaw's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Asfaw is board certified in internal medicine by the American Board of Internal Medicine. Dr. Asfaw is licensed in California.

Dmand AI lists acid reflux, acute gallbladder or bile duct inflammation, acute kidney failure, acute respiratory failure, acute sinusitis, acute skin infection, aneurysm and arthritis among the conditions Dr. Asfaw treats.

CMS data shows 361 Medicare services from Dr. Asfaw across 5 procedure codes in 2024, for 151 Medicare patients. Medicare paid $21,901 for them.

CMS counts 151 Medicare patients who saw Dr. Asfaw in 2024. The largest group is 65 to 74, with 70 patients. 73% of them have high cholesterol, and 70% have high blood pressure. 41% are also on Medicaid. Their average risk score is 2.53, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Asfaw's median patient age at 54, with 67% women.

In 2024, Dr. Asfaw wrote 2,195 Medicare Part D claims for 193 patients. 87% of them were for generic drugs. CMS names the drug for 1,620 of them, across 61 drugs with 11 or more claims each, at $119,985 in total drug cost. In 2023, CMS named 1,293 claims across 53 drugs.

Dr. Asfaw accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Asfaw as offering telehealth.

Dmand AI links 1 paper to Dr. Asfaw in 2014. Dr. Asfaw's most frequent co-author is Robert Scott Ross, MD.

Dr. Asfaw graduated from David Geffen School of Medicine at UCLA in 2017.

Dr. Asfaw is in network with 13 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.